Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: A systematic review

Journal of Infection and Public Health

Volumn 8, Issue 1, 2015, Pages 1-10

  Cobucci, Ricardo Ney Oliveira ^a,b   Lima, Paulo Henrique ^a   de Souza, Pollyana Carvalho ^b   Costa, Vanessa Viana ^b   Cornetta, Maria da Conceição de Mesquita ^a   Fernandes, José Veríssimo ^a   Gonçalves, Ana Katherine ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b POTIGUAR UNIVERSITY   (Brazil)

Author keywords

Acquired immunodeficiency syndrome; Carcinoma; Highly active antiretroviral therapy; Incidence

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS PATIENT; ANUS CANCER; CANCER RISK; DEFINING AIDS CANCER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INVASIVE CERVICAL CANCER; KAPOSI SARCOMA; LIVER CANCER; LUNG CANCER; NEOPLASM; NON DEFINING AIDS CANCER; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; COHORT ANALYSIS; FEMALE; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; MALE; OBSERVATIONAL STUDY; SARCOMA, KAPOSI; UTERINE CERVICAL NEOPLASMS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; FEMALE; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; MALE; OBSERVATIONAL STUDY AS TOPIC; SARCOMA, KAPOSI; UTERINE CERVICAL NEOPLASMS;

EID: 84920673016     PISSN: 18760341     EISSN: 1876035X     Source Type: Journal    
DOI: 10.1016/j.jiph.2014.08.003     Document Type: Review

References (43)

1. Bower M., Palmieri C., Dhillon T. AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis 2006, 19:14-19.
2. Bonnet F., Lewden C., May T., Heripret L., Jougla E., Bevilacqua S., et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 2004, 101:317-324.
3. Silverberg M.J., Abrams D.I. AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era. Curr Opin Oncol 2007, 19:446-451.
4. Crum-Cianflone N., Hullsiek K.H., Marconi V., Weintrob A., Ganesan A., Barthel R.V., et al. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS 2009, 23:41-50.
5. International Collaboration on HIV and Cancer Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000, 92:1823-1830.
6. Oliveira Cobucci R.N., Saconato H., Lima P.H., Rodrigues H.M., Prudencio T.L., Junior J.E., et al. Comparative incidence of cancer in HIV-AIDS patients and transplant recipients. Cancer Epidemiol 2012, 36:e69-e73.
7. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
8. Lo C.K., Mertz D., Loeb M. Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments. BMC Med Res Methodol 2014, 14:45.
9. Olivero O.A. Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors. Environ Mol Mutagen 2007, 48(3-4):215-223.
10. Franzetti M., Adorni F., Parravicini C., Vergani B., Antinori S., Milazzo L., et al. Trends and predictors of non AIDS-defining cancers in men and women with HIV-infection. A single-institution retrospective study before and after the introduction of HAART. J Acquir Immune Defic Syndr 2013, 62(4):414-420.
11. Legarth R., Helleberg M., Kronborg G., Larsen C.S., Pedersen G., Pedersen C., et al. Anal carcinoma in HIV-infected patients in the period 1995-2009: a Danish nationwide cohort study. Scand J Infect Dis 2013, 45(6):453-459.
12. Grulich A.E. Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation. Curr Opin HIV AIDS 2009, 4:183-187.
13. Van der Snoek E.M., van der Ende M.E., den Hollander J.C., Schutten M., Neumann H.A., van Doornum G.J. Use of highly active antiretroviral therapy is associated with lower prevalence of anal intraepithelial neoplastic lesions and lower prevalence of human papillomavirus in HIV-infected men who have sex with men. Sex Transm Dis 2012, 39:495-500.
14. Palefsky J.M. Antiretroviral therapy and anal cancer: the good, the bad, and the unknown. Sex Transm Dis 2012, 39:501-503.
15. Biggar R.J., Jaffe E.S., Goedert J.J., Chaturvedi A., Pfeiffer R., Engels E.A. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 2006, 108:3786-3791.
16. Clifford G.M., Polesel J., Rickenbach M., Dal Maso L., Keiser O., Kofler A., et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005, 97:425-432.
17. Herida M., Mary-Krause M., Kaphan R., Cadranel J., Poizot-Martin I., Rabaud C., et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 2003, 21:3447-3453.
18. Sahasrabuddhe V.V., Shiels M.S., McGlynn K.A., Engels E.A. The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States. Cancer 2012, 118:6226-6233.
19. Pinzone M.R., Fiorica F., Di Rosa M., Malaguarnera G., Malaguarnera L., Cacopardo B., et al. Non-AIDS-defining cancers among HIV-infected people. Eur Rev Med Pharmacol Sci 2012, 16:1377-1388.
20. van Leeuwen M.T., Vajdic C.M., Middleton M.G., McDonald A.M., Law M., Kaldor J.M., et al. Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS 2009, 23:2183-2190.
21. Polesel J., Franceschi S., Suligoi B., Crocetti E., Falcini F., Guzzinati S., et al. Cancer incidence in people with AIDS in Italy. Int J Cancer 2010, 127(6):1437-1445.
22. Silberstein J., Downs T., Lakin C., Kane C.J. HIV and prostate cancer: a systematic review of the literature. Prostate Cancer Prostatic Dis 2009, 12:6-12.
23. Pantanowitz L., Bohac G., Cooley T.P., Aboulafia D., Dezube B.J. Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study. BJU Int 2008, 101:1519-1523.
24. Kirk O., Pedersen C., Cozzi-Lepri A., Antunes F., Miller V., Gatell J.M., et al. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 2001, 98:3406-3412.
25. Patel P., Hanson D.L., Sullivan P.S., Novak R.M., Moorman A.C., Tong T.C., et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008, 148:728-736.
26. Gingues S., Gill M.J. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta. HIV Med 2006, 7(6):369-377.
27. Dorrucci M., Suligoi B., Serraino D., Tirelli U., Rezza G. Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2001, 26:377-380.
28. Frisch M., Biggar R.J., Goedert J.J. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000, 92:1500-1510.
29. Bower M., Powles T., Nelson M., Shah P., Cox S., Mandelia S., et al. HIV-related lung cancer in the era of highly active antiretroviral therapy. AIDS 2003, 17:371-375.
30. Bower M., Powles T., Newsom-Davis T., Thirlwell C., Stebbing J., Mandalia S., et al. HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome. J Acquir Immune Defic Syndr 2004, 37:1563-1565.
31. Hessol N.A., Seaberg E.C., Preston-Martin S., Massad L.S., Sacks H.S., Silver S., et al. Cancer risk among participants in the women's interagency HIV study. J Acquir Immune Defic Syndr 2004, 36:978-985.
32. D'Souza G., Wiley D.J., Li X., Chmiel J.S., Margolick J.B., Cranston R.D., et al. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2008, 48:491-499.
33. Franceschi S., Maso L.D., Rickenbach M., Polesel J., Hirschel B., Cavassini M., et al. Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Br J Cancer 2008, 99:800-804.
34. Polesel J., Clifford G.M., Rickenbach M., Dal Maso L., Battegay M., Bouchardy C., et al. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS 2008, 22:301-306.
35. Engels E.A., Biggar R.J., Hall H.I., Cross H., Crutchfield A., Finch J.L., et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008, 123:187-194.
36. Clifford G.M., Rickenbach M., Lise M., Dal Maso L., Battegay M., Bohlius J., et al. Hodgkin lymphoma in the Swiss HIV Cohort Study. Blood 2009, 113:5737-5742.
37. Buchacz K., Baker R.K., Palella F.J., Chmiel J.S., Lichtenstein K.A., Novak R.M., et al. AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study. AIDS 2010, 24:1549-1559.
38. Besson C., Goubar A., Gabarre J., Rozenbaum W., Pialoux G., Chatelet F.P., et al. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 2001, 98:2339-2344.
39. Crum-Cianflone N.F. HIV and the Gastrointestinal Tract. Infect Dis Clin Pract (Baltim, MD) 2010, 18:283-285.
40. Seaberg E.C., Wiley D., Martinez-Maza O., Chmiel J.S., Kingsley L., Tang Y., et al. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Cancer 2010, 116:5507-5516.
41. Powles T., Robinson D., Stebbing J., Shamash J., Nelson M., Gazzard B., et al. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol 2009, 27:884-890.
42. Franceschi S., Lise M., Clifford G.M., Rickenbach M., Levi F., Maspoli M., et al. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer 2010, 103:416-422.
43. Dal Maso L., Polesel J., Serraino D., Lise M., Piselli P., Falcini F., et al. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer 2009, 100:840-847.